Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy.
Santana-Magal N, Farhat-Younis L, Gutwillig A, Gleiberman A, Rasoulouniriana D, Tal L, Netanely D, Shamir R, Blau R, Feinmesser M, Zlotnik O, Gutman H, Linde IL, Reticker-Flynn NE, Rider P, Carmi Y. Santana-Magal N, et al. Among authors: gleiberman a. Cancer Res. 2020 May 15;80(10):1942-1956. doi: 10.1158/0008-5472.CAN-19-2944. Epub 2020 Mar 3. Cancer Res. 2020. PMID: 32127354
Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy.
Gutwillig A, Santana-Magal N, Farhat-Younis L, Rasoulouniriana D, Madi A, Luxenburg C, Cohen J, Padmanabhan K, Shomron N, Shapira G, Gleiberman A, Parikh R, Levy C, Feinmesser M, Hershkovitz D, Zemser-Werner V, Zlotnik O, Kroon S, Hardt WD, Debets R, Reticker-Flynn NE, Rider P, Carmi Y. Gutwillig A, et al. Among authors: gleiberman a. Elife. 2022 Sep 20;11:e80315. doi: 10.7554/eLife.80315. Elife. 2022. PMID: 36124553 Free PMC article.
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.
Vylegzhanina AV, Bespalov IA, Novototskaya-Vlasova KA, Hall BM, Gleiberman AS, Yu H, Leontieva OV, Leonova KI, Kurnasov OV, Osterman AL, Dy GK, Komissarov AA, Vasilieva E, Gehlhausen J, Iwasaki A, Ambrosone CB, Tsuji T, Matsuzaki J, Odunsi K, Andrianova EL, Gudkov AV. Vylegzhanina AV, et al. Among authors: gleiberman as. Cancer Res Commun. 2023 Nov 8;3(11):2256-2267. doi: 10.1158/2767-9764.CRC-23-0289. Cancer Res Commun. 2023. PMID: 37870410 Free PMC article.
Inflammatory response to retrotransposons drives tumor drug resistance that can be prevented by reverse transcriptase inhibitors.
Novototskaya-Vlasova KA, Neznanov NS, Molodtsov I, Hall BM, Commane M, Gleiberman AS, Murray J, Haber M, Norris MD, Leonova KI, Gudkov AV. Novototskaya-Vlasova KA, et al. Among authors: gleiberman as. Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2213146119. doi: 10.1073/pnas.2213146119. Epub 2022 Nov 30. Proc Natl Acad Sci U S A. 2022. PMID: 36449545 Free PMC article.
Resistance of bone marrow stroma to genotoxic preconditioning is determined by p53.
Fedtsova N, Komarova EA, Greene KF, Novototskaya LR, Molodtsov I, Brackett CM, Strom E, Gleiberman AS, Shakhov AN, Gudkov AV. Fedtsova N, et al. Among authors: gleiberman as. Cell Death Dis. 2021 May 26;12(6):545. doi: 10.1038/s41419-021-03824-3. Cell Death Dis. 2021. PMID: 34039962 Free PMC article.
Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue.
Hall BM, Gleiberman AS, Strom E, Krasnov PA, Frescas D, Vujcic S, Leontieva OV, Antoch MP, Kogan V, Koman IE, Zhu Y, Tchkonia T, Kirkland JL, Chernova OB, Gudkov AV. Hall BM, et al. Among authors: gleiberman as. Aging Cell. 2020 Oct;19(10):e13219. doi: 10.1111/acel.13219. Epub 2020 Aug 28. Aging Cell. 2020. PMID: 32856419 Free PMC article.
Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer.
Antoch MP, Wrobel M, Gillard B, Kuropatwinski KK, Toshkov I, Gleiberman AS, Karasik E, Moser MT, Foster BA, Andrianova EL, Chernova OV, Gudkov AV. Antoch MP, et al. Among authors: gleiberman as. Oncotarget. 2020 Apr 14;11(15):1373-1387. doi: 10.18632/oncotarget.27550. eCollection 2020 Apr 14. Oncotarget. 2020. PMID: 32341756 Free PMC article.
Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy.
Mett V, Komarova EA, Greene K, Bespalov I, Brackett C, Gillard B, Gleiberman AS, Toshkov IA, Aygün-Sunar S, Johnson C, Karasik E, Bapardekar-Nair M, Kurnasov OV, Osterman AL, Stanhope-Baker PS, Morrison C, Moser MT, Foster BA, Gudkov AV. Mett V, et al. Among authors: gleiberman as. Oncogene. 2018 Jan 25;37(4):439-449. doi: 10.1038/onc.2017.346. Epub 2017 Oct 2. Oncogene. 2018. PMID: 28967901 Free PMC article.
71 results